Bureaucrats, developer, Administrators
9,854
edits
(→Alzheimer's and cannabis: 2x reporting on the 2017 w:University of Bonn and w:Hebrew University of Jerusalem study (sciencedaily.com & jpost.com)) |
(→Alzheimer's and cannabis: + ''''''A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC'''''' at ncbi.nlm.nih.gov, a '''2019''' literature review published in the Journal of Pharmacopuncture (JoP)) |
||
Line 19: | Line 19: | ||
''' Scientific research about Alzheimer's and cannabis ''' | ''' Scientific research about Alzheimer's and cannabis ''' | ||
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970569/ ''''''A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC'''''' at ncbi.nlm.nih.gov], a '''2019''' literature review published in the [https://www.journal-jop.org/main.html Journal of Pharmacopuncture (JoP)] - "''These results implied that the CBD components of cannabis might be useful to treat and prevent AD because CBD components could suppress the main causal factors of AD. Moreover, it was suggested that using CBD and THC together could be more useful than using CBD or THC alone.''" (results section) | |||
* [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h6 ''''''Cannabis Therapeutics and the Future of Neurology: Cannabis and Alzheimer Disease (AD)''''''], a '''2018''' perspectives article published in Frontiers in Integrative Neuroscience. | * [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h6 ''''''Cannabis Therapeutics and the Future of Neurology: Cannabis and Alzheimer Disease (AD)''''''], a '''2018''' perspectives article published in Frontiers in Integrative Neuroscience. |